eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Amicus Therapeutics, Inc - Comment

Amicus Therapeutics, Inc - Comment

Document ID: FDA-2012-N-1248-0036
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 01 2013, at 12:00 AM Eastern Standard Time
Date Posted: March 20 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: January 14 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 1 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-83yh-e0bw
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Amicus Therapeutics Inc Comments Feb 4 FDA hearing on accelerating approval

Title:
Amicus Therapeutics Inc Comments Feb 4 FDA hearing on accelerating approval

View Attachment: View as format msw12 View as format pdf

Related Comments

    View All
Total: 42
Amicus Therapeutics, Inc - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2012-N-1248-0036

Mar 01,2013 11:59 PM ET
National Research Center for Women & Families - Testimony
Public Submission    Posted: 03/20/2013     ID: FDA-2012-N-1248-0022

Mar 01,2013 11:59 PM ET
Steven Gerard Chilinski - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-N-1248-0007

Mar 01,2013 11:59 PM ET
Parkinson's Action Network - Comment
Public Submission    Posted: 03/19/2013     ID: FDA-2012-N-1248-0009

Mar 01,2013 11:59 PM ET
Institute for Safe Medication Practices - Comment
Public Submission    Posted: 03/20/2013     ID: FDA-2012-N-1248-0030

Mar 01,2013 11:59 PM ET